Dr. Jagdish Singh
102 Sudro Hall
March 15 for fall semester and November 15 for spring semester, if positions are available.
GRE (300 or more)
English Proficiency Requirements
TOEFL ibT 79
The Department of Pharmaceutical Sciences offers graduate study leading to the Doctor of Philosophy degree. Advanced work may be selected from pharmaceutics, pharmacokinetics, pharmacology, and medicinal chemistry.
The pharmaceutical sciences curriculum consists of a core of courses involving both basic and pharmaceutical sciences. In addition, students will select courses that will prepare them to be competent scientists in their fields.
The Department of Pharmaceutical Sciences graduate program is open to all qualified graduates of recognized universities and colleges. In addition to the Graduate School admission requirements, the applicant must have adequate preparation in pharmacy or a biological or physical science related to pharmaceutical sciences.
A limited number of assistantships is available. To be considered for an assistantship, the student must have completed a Graduate School application, be accepted by the department, and submit a formal letter to the department chair requesting an assistantship.
The Doctor of Philosophy program requires the completion of 30 semester credits of letter-graded course work with a GPA of 3.0 or better. Out of the 30 credits at least 18 credits must be at 700 level. Candidates defend their dissertations. Candidates for the Ph.D. will be required to take an examination directed at determining competency in the pharmaceutical sciences.
The department requires the following core courses:
PSCI 611 Pharmacodynamics and Applied Therapeutics I
PSCI 670 Pharmacokinetics
PSCI 790 Graduate Seminar
BIOC 701 Comprehensive Biochemistry I
BIOC 702 Comprehensive Biochemistry II
STAT 725 Applied Statistics
Bin Guo, Ph.D.
State University of New York at Buffalo, 1999
Postdoctoral: Burnham Institute, La Jolla, CA. 1999 - 2003
Research interests: Molecular and cell biology of apoptosis; cancer
Yagna Jarajapu, M.Pharm., Ph.D.
University of Strathclyde, 1998
Glasgow Caledonian University, 2002
Postdoctoral: University of Florida, and Wake Forest University 2003-2008
Research Interests: ACE2/Angiotensin-(1-7) and Bone Marrow Progenitor Cells in Diabetes
Benedict Law, Ph.D.
University of Manchester, 2002
Postdoctoral : Massachusetts General Hospital/Harvard Medical School, 2002-2007
Research Interests: Drug delivery, imaging, and nanotechnology
Estelle Leclerc, Ph.D.
University Paris XI, 1994
Postdoctoral: ETH-Zurich (Switzerland): 1994-1998 The Scripps Research Institute (La Jolla, CA): 1998-2003 Junior Group Leader Children's Hospital Zurich (Switzerland): 2004 Research Assistant Professor Florida Atlantic University (FL): 2005-2009
Research Interests: Biopharmaceutics
Sanku Mallik, Ph.D.
Case Western Reserve University, 1992
Postdoctoral: California Institute of Technology, 1993-95
Research Interests: Synthetic medicinal chemistry
Stephen T. O'Rourke, Ph.D.
University of Wisconsin, 1985
Postdoctoral: Mayo Clinic and Foundation, 1985-87
Research Interests: Vascular Pharmacology
Steven Qian, Ph.D.
The University of Iowa, 1999
Postdoctoral: National Institute of Environmental Health Science (NIEHS, NIH) 2000-2004
Research Interests: Roles of lipid-derived and protein-derived free radical metabolites in all kinds of health related problems
R. Craig Schnell, Ph.D.
Purdue University, 1969
Jagdish Singh, Ph.D.
Banaras Hindu University, 1982
Postdoctoral: University of Otago, New Zealand, 1985-88; University of California--San Francisco, 1992-94
Research Interests: Novel Dosage and Drug Delivery Systems, Biopharmaceutics
Kristine Steffen, Pharm.D., Ph.D.
North Dakota State University, 2002
North Dakota State University, 2007
Postdoctoral: Neuropsychiatric Research Institute, 2007-2009
Research Interests: Pharmacokinetics, Bariatric Surgery, Eating Disorder and Obesity Pharmacotherapy
Chengwen Sun, M.D., Ph.D.
Norman Bethune University of Medical Sciences, 1983-1988
Immunology, Norman Bethune University of Medical Sciences, China, 1990-1996
Postdoctoral: Department of Physiology, Medical College of Wisconsin, 1996-2000
Research Interests: Central blood pressure control and hypertension gene therapy
Stefan Vetter, Ph.D.
Swiss Institute of Technology (ETH) Zurich,1998
Postdoctoral: The Scripps Research Institute, La Jolla, 2000-2005
Research Interest: Medicinal Protein Biochemistry
Erxi Wu, Ph.D.
Sheffield University, 1998
Postdoctoral: Dana-Farber Cancer Institute/Harvard Medical School, 1998-2004
Faculty: Children's Hospital Boston/Harvard Medical School, 2005-2008
Research Interests: Cancer therapeutic targets, drug discovery, natural products, blood biomarker for cancer